Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperbaric Oxygen Therapy in Sickle Cell Pain

NCT03412045 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT03412045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03412045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperbaric Oxygen Therapy in Sickle Cell Pain
Lead sponsor
University of Nebraska
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2022
Completion date
June 5, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell anemia crisis, vaso-occlusive crisis